Pharma

Your Article Summary

See Latest Articles

Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09

GlaxoSmithKline announced that it has filed a supplemental New Drug Application for Avodart with the US Food and Drug Administration for prostate cancer risk reduction among men at increased risk of developing the disease. EU filings also are underway via the European Mutual Recognition Variation Procedure, with Sweden acting as the Reference Member State.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09

Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09

Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09

 See all of Drug/Product Approvals

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senates Revised Medical Device Industry Fee Proposal
Medtronic, 11/20/09

Sanofi-aventis and Medicines for Malaria Venture to launch the largest ever study of an antimalarial drug
Sanofi-aventis, 11/20/09

Philips developing digital pathology solutions
Canadian Healthcare Technology, 11/20/09

 See all of Medical Devices/Products

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

Leavitt Leaving CCHIT
HealthDataManagement, 11/20/09

AzHHAs Rivers to retire in 2011
American Hospital Association News, 11/16/09

 See all of Regulatory Issues